Many people are confused about whether they should switch vaccines for the booster dose or stick with the one they know.

Collins estimates that the FDA would need about three weeks to analyze the trial data, after which an expert advisory panel will meet and v...

Moderna's COVID-19 vaccine mRNA-1273 on Friday became the second drug in the US to get emergency use authorisation from the US FDA, a week ...

The Food and Drug Administration said in documents posted online that its initial review confirmed the effectiveness and safety of the vacc...

The agreement brings the total number of Moderna doses bought by the US to 200 million, enough to immunize 100 million people with the two-...

"Translating pharma lingo: the announced price of Pfizer of USD 19.50 and Moderna of USD 25-USD 37 per dose actually means their price of U...

Moderna Inc. and competitor Pfizer Inc. recently announced preliminary results showing their vaccines appear more than 90% effective, at le...

To make up for the shortfall, Moderna slowed enrollment of its late-stage trial and instructed research centers to focus on increasing part...

Earlier this week, the UK-Swedish company reportedly froze the trials after discovering that one participant was sick with transverse myeli...

AstraZeneca is one of the leaders in the race to develop COVID-19 vaccine. Other companies that have COVID-19 vaccines in phase 3 trials in...

Final-stage testing of the vaccine, developed by the National Institutes of Health and Moderna Inc., began on Monday with volunteers at num...

The trial is the first such late-stage study under the Trump administration's program to speed development of measures against the novel co...

The Moderna vaccine candidate is an RNA-based vaccine designed to help the body produce antibodies that protect against Covid-19.

Race for the vaccine enters a defining summer, with even bigger studies poised to prove if any shot really works.

The vaccine is called mRNA-1273 and was developed by the NIAID scientists and their collaborators at the biotechnology company Moderna, Inc...

Studies have suggested that coronavirus vaccines carry the risk of what is known as vaccine enhancement, where instead of protecting agains...

Officials are also worried the outbreak poses a threat to the security of the US drug supply chain because a high proportion of ingredients...